Predictive Oncology Inc
NASDAQ:POAI
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
4.26
29.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shareholder Yield
Current shareholder yield for
POAI is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
POAI Price
Predictive Oncology Inc
| Average Annual Return | -39.09% |
| Standard Deviation of Annual Returns | 31.83% |
| Max Drawdown | -99% |
| Market Capitalization | 18.6m USD |
| Shares Outstanding | 3 390 000 |
| Percentage of Shares Shorted | 2.33% |
Stock Splits
POAI's latest stock split occurred on Sep 30, 2025
The company executed a 1-for-15 stock split, meaning that for every 15 shares held, investors received 1 new share.
Before the split, POAI traded at 1.2 per share. Afterward, the share price was about 14.22.
The adjusted shares began trading on Sep 30, 2025. This was POAI's 5th stock split, following the previous one in Apr 24, 2023.